Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine for Postoperative Bowel Function Recovery in Abdominal Surgery
NCT07412223Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegileridine in postoperative pain, postoperative ileus (POI), sponsored by Xiangya Hospital, Central South University. Started Feb 2026; status: recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT07412223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07412223.